| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | 0.024 | 0.9 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.9 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | 0.0072 | 0.9 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | 0.02 | 0.9 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | 0.0064 | 0.9 |